**Study Overview:**
This study looks at how well two different asthma treatments work for adults. One treatment is called FF/UMEC/VI, a combination of three medicines in an inhaler. The other is the usual care using ICS/LABA, which are inhaled corticosteroids and long-acting beta-2 agonists that help open airways.
**Eligibility:**
To join, you must have asthma diagnosed by a doctor and have been using some asthma treatment or none at all. You need to score 1.5 or higher on the ACQ-6, a test that checks asthma control, and be able to answer questions for the study. You cannot join if you have recently had very severe asthma attacks, use certain asthma medicines, are pregnant, or have other specific health issues.
**Key Points:**
- **Study Duration:** The exact length is not mentioned, but you'll need to attend regular visits.
- **Treatment Details:** You'll either receive the FF/UMEC/VI inhaler or continue with your usual asthma care.
- **Risks and Compensation:** The study will explain any risks or benefits, and if there is payment for participation.
**Note:** If you are considering participating, discuss with your doctor to ensure it is a good fit for your health needs.
How understandable was the trial content above?
Hard to understand
Easy to understand